Article Text
Case report
p53 gene (Gendicine) and embolisation overcame recurrent hepatocellular carcinoma
Abstract
Transcatheter arterial chemoembolisation (TACE) has become the standard treatment for unresectable hepatocellular carcinoma (HCC). However, this method is often unsuccessful. The p53 gene, which is present as a mutant form in many human tumours, is known to have broad spectrum antitumour effects when expressed normally. In this study, we report a 23 year old patient with recurrent HCC who was treated with the p53 gene (Gendicine) combining TACE, which resulted in a good clinical prognosis.
- TACE, transcatheter arterial chemoembolisation
- HCC, hepatocellular carcinoma
- CT, computed tomography
- VP, virus particles
- hepatocellular carcinoma
- p53 gene
- transcatheter arterial chemoembolisation
Statistics from Altmetric.com
Footnotes
-
Conflict of interest: None declared.
Linked Articles
- Notice of withdrawal